In agreement with this, stimulation of ephrinB2 reverse signalling with its cognate receptor EphB4 decreased invasion in human glioma cell lines that express ephrinB2 (Supplementary Figs 4a,5). The gene discussed is EPHB4; the disease is central nervous system cancer.